No definition available.
Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
C3_THYROID_PAPILLARY_ADENO_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
2494 |
4. Check minimum number of eventsNone |
2494 |
5. Include endpointsNone |
2494 |
6. Filter based on genotype QC (FinnGen only) |
2494 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2494 | 1890 | 604 |
| Unadjusted period prevalence (%) | 0.55 | 0.64 | 0.27 |
| Median age at first event (years) | 51.24 | 49.15 | 57.77 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1815
- Matched controls
- 18151
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
323.0
1597
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
323.0
1815
*
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
91.5
323.0
528
81
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
102.7
323.0
420
53
BAA60
NOMESCO Finland
Total thyroidectomy
196.8
323.0
1094
139
H03AA01
ATC
levothyroxine sodium; systemic
125.8
323.0
1748
3116
EP1AE
NOMESCO Finland
Neck ultrasound examination
56.0
323.0
913
322
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
211.7
323.0
527
35
104
Kela drug reimbursment
Thyroid insufficiency
83.8
323.0
1417
738
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
323.0
487
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
305.0
284
*
ZX114
NOMESCO Finland
Intramuscular
65.6
296.4
342
64
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
285.1
266
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.1
274.7
1103
3664
4CJ01
NOMESCO Finland
NA
+∞
260.9
244
*
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
2565.7
249.7
236
*
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
26.1
224.3
319
147
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
221.5
208
*
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
+∞
211.7
199
*
130
Kela drug reimbursment
Malignant tumour
+∞
203.0
191
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
38.6
196.2
251
75
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
174.9
165
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
29.4
156.4
214
82
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
154.4
146
*
115
Kela drug reimbursment
Breast cancer
+∞
141.5
134
*
2506
FHL
Thyroidectomy
248.6
136.0
138
6
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
67.2
133.6
154
25
T71
ICPC
Malignant neoplasm thyroid
+∞
133.0
126
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
105.8
126.0
137
14
A11CC03
ATC
alfacalcidol; systemic
19.5
125.7
195
111
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
130.3
124.9
133
11
106
Kela drug reimbursment
Hypoparathyroidism
185.0
116.9
121
7
PJA12
NOMESCO Finland
Sentinel node biopsy
1180.1
114.9
111
*
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
9.0
113.2
253
319
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
111.9
687
2695
H02AB02
ATC
dexamethasone; systemic
20.0
108.1
166
91
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
+∞
107.4
102
*
Z51.88
ICD-10 Finland
Other specified medical care
17.7
102.9
165
102
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.6
98.6
554
1988
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
989.2
96.9
94
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.9
93.0
837
4153
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
91.4
87
*
C739
ICD-10 Finland
NA
+∞
87.2
83
*
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
94.7
81.8
90
10
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
79.8
676
3149
A04AA02
ATC
granisetron; systemic, transdermal
112.8
79.6
86
8
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
16.3
75.4
124
81
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
70.3
67
*
A11CC02
ATC
dihydrotachysterol; oral
111.7
69.4
75
7
WX402
NOMESCO Finland
General anaesthesia
3.3
68.1
398
1418
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
45.7
67.6
83
19
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
86.9
67.5
75
9
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
67.1
64
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.6
65.9
332
1050
HAC20
NOMESCO Finland
Total mastectomy
228.1
64.6
66
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
628.9
62.2
61
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
22.2
62.0
91
43
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
10.8
61.7
122
120
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
60.8
58
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
60.8
58
*
L02BA01
ATC
tamoxifen; oral
112.3
60.2
65
6
JN4BD
NOMESCO Finland
Extensive body CT
6.1
60.1
172
304
A12AA04
ATC
calcium carbonate; oral
16.5
57.7
94
60
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
56.6
802
4693
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
56.5
54
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
50.4
56.5
68
14
WF002
NOMESCO Finland
Radical radiotherapy
81.6
56.3
63
8
E83.51
ICD-10 Finland
Hypocalcemia
29.3
56.1
76
27
HA1AA
NOMESCO Finland
X-ray mammography
6.8
55.9
148
235
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
8.3
55.5
127
162
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
54.4
52
*
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
20.4
54.4
82
42
WF003
NOMESCO Finland
Adjuvant radiotherapy
532.8
52.8
52
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
6.3
52.0
144
243
C61
ICD-10 Finland
Malignant neoplasm of prostate
181.8
51.2
53
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
50.2
48
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
50.2
48
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
50.2
48
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
49.2
47
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.5
48.1
130
212
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
62.9
47.5
55
9
XX3DW
NOMESCO Finland
Time consuming IT work
5.0
47.3
162
352
GD1AD
NOMESCO Finland
Thorax CT examination
6.4
47.0
128
211
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
469.3
46.5
46
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.5
46.3
175
421
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
46.0
44
*
A12AA06
ATC
calcium lactate gluconate; oral
120.5
43.9
47
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
427.2
42.3
42
*
JN5SN
NOMESCO Finland
NA
+∞
41.8
40
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.7
41.3
332
1411
HAB40
NOMESCO Finland
Wedge excision of mammary gland
16.3
38.8
63
40
A04AA55
ATC
palonosetron, combinations; systemic
+∞
38.7
37
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
38.7
37
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
38.7
37
*
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
15.4
38.6
64
43
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
199.1
37.9
39
*
WZC30
NOMESCO Finland
Teaching
2.9
36.7
240
893
JN4AD
NOMESCO Finland
Body CT examination
5.8
36.6
107
193
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
+∞
36.6
35
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.4
36.1
88
124
L02BG04
ATC
letrozole; oral
8.6
35.8
79
95
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
129.3
35.8
38
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.3
35.4
197
655
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
30.1
35.2
47
16
WW200
NOMESCO Finland
Immunization
6.4
34.7
94
154
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
64.6
33.1
38
6
ZX070
NOMESCO Finland
Intensity modified radiotherapy
332.9
33.0
33
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
32.4
31
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
32.4
31
*
ZXA10
NOMESCO Finland
Bilateral
2.2
32.0
394
2051
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
31.9
717
4721
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.6
31.5
113
257
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
31.3
30
*
T86
ICPC
Hypothyroidism/myxoedema
4.0
31.1
132
353
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.1
30.5
123
314
A04AA01
ATC
ondansetron; systemic, rectal
5.6
29.5
89
167
ZX090
NOMESCO Finland
Other technic of radiotherapy
296.5
28.8
29
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
28.2
27
*
L01BC06
ATC
capecitabine; oral
+∞
28.2
27
*
116
Kela drug reimbursment
Prostate cancer
+∞
28.2
27
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
28.2
27
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
28.2
27
*
C50
ICD-10 Finland
Malignant neoplasm of breast
285.7
27.8
28
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
27.1
26
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
27.1
26
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.3
26.9
60
74
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
46.5
26.5
32
7
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
26.1
25
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
26.1
25
*
GD6AD
NOMESCO Finland
CT of chest and neck
73.8
25.8
29
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.1
25.6
103
262
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.8
25.6
112
308
ZXA05
NOMESCO Finland
Left side
1.9
25.4
454
2713
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
25.4
25.3
35
14
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
25.1
24
*
JN6AD
NOMESCO Finland
CT of torso and neck
21.6
24.8
36
17
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
7.4
24.6
59
82
N02BE01
ATC
paracetamol; systemic, rectal
1.9
24.5
1544
13533
A04AD12
ATC
aprepitant; systemic
+∞
24.0
23
*
BA1AQ
NOMESCO Finland
Thyroid SPECT with low dose CT
+∞
24.0
23
*
XX1MN
NOMESCO Finland
Isotope examination with measurement
+∞
24.0
23
*
E8901, C7391
ICD-10 Finland
NA
+∞
24.0
23
*
L03AA02
ATC
filgrastim; parenteral
47.3
23.3
28
6
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
54.7
23.1
27
5
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
23.0
22
*
BAA99
NOMESCO Finland
Other operation on thyroid gland
121.5
22.6
24
*
Z51.5
ICD-10 Finland
Palliative care
6.5
22.1
58
92
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
35.5
22.1
28
8
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
21.9
21
*
198
Kela drug reimbursment
Sorafenib
+∞
21.9
21
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
21.9
21
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
21.9
21
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
8.7
21.9
47
55
ZSB00
NOMESCO Finland
Procedure related to previous procedure classified in chapter B
81.1
21.7
24
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
222.5
21.6
22
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
116.4
21.6
23
*
WX704
NOMESCO Finland
Intubation
2.7
21.5
150
577
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
20.9
20
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
20.9
20
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
11.0
20.7
39
36
ZX080
NOMESCO Finland
Image guided radiotherapy
111.3
20.6
22
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
48.6
20.2
24
5
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
6.4
19.8
52
83
TQW20
NOMESCO Finland
Tatoe
74.3
19.7
22
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
5.1
19.7
62
124
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
19.2
399
2476
NK6AN
NOMESCO Finland
Total body bone isotope imaging
20.3
19.1
28
14
ZXE00
NOMESCO Finland
One hour or less
1.6
18.9
690
5020
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
18.8
18
*
X76
ICPC
Malignant neoplasm breast female
191.9
18.6
19
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
11.2
18.2
34
31
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
17.7
17
*
1930X
ICD-9 Finland
Malignant neoplasm of thyroid gland[NEOPLASMA MALIGNUM THYREOIDEAE EI HISTOL VAHV]
+∞
17.7
17
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
17.7
17
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
96.0
17.6
19
*
L03AA14
ATC
lipegfilgrastim; parenteral
181.7
17.5
18
*
Z3226
NOMESCO Finland
Physiotherapist
1.8
17.5
311
1827
ZXA00
NOMESCO Finland
Right side
1.7
17.0
451
2995
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
8.7
16.9
36
42
N02AA05
ATC
oxycodone; systemic
2.2
16.9
180
861
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
63.9
16.8
19
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
63.9
16.8
19
*
R49.01
ICD-10 Finland
Functional dysphonia
3.3
16.7
84
260
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
16.7
16
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
90.9
16.6
18
*
2504
FHL
Unilateral resection or enucleation
8.0
16.6
37
47
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
171.5
16.5
17
*
B01AB05
ATC
enoxaparin; parenteral
1.6
16.5
467
3155
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
9.6
16.4
33
35
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.8
16.3
106
391
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.8
15.9
103
379
Z50.5
ICD-10 Finland
Speech therapy
6.7
15.9
40
61
Z31.5
ICD-10 Finland
Genetic counselling
3.0
15.7
95
333
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
15.6
15
*
323
Kela drug reimbursment
Sorafenib
+∞
15.6
15
*
1AB01
NOMESCO Finland
NA
+∞
15.6
15
*
L01XE05
ATC
[U] sorafenib; oral
+∞
15.6
15
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
15.6
15
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
15.6
15
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
7.2
15.6
37
52
E20.8
ICD-10 Finland
Other hypoparathyroidism
161.3
15.5
16
*
Y77
ICPC
Malignant neoplasm prostate
161.3
15.5
16
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
161.3
15.5
16
*
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
38.4
15.4
19
5
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
15.0
319
1978
JN4CD
NOMESCO Finland
Very extensive body CT
5.0
14.8
47
96
A79
ICPC
Malignancy NOS
57.1
14.8
17
*
S18
ICPC
Laceration/cut
1.5
14.8
647
4843
XX9XW
NOMESCO Finland
NA
10.5
14.7
28
27
L02BG06
ATC
exemestane; oral
+∞
14.6
14
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
14.6
14
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
14.6
14
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
14.6
14
*
WA039
NOMESCO Finland
Radiotherapy with free isotopes
+∞
14.6
14
*
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
6.3
14.6
38
61
PJA10
NOMESCO Finland
Exploration of lymph nodes
10.1
14.5
28
28
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
36.3
14.4
18
5
L02BG03
ATC
anastrozole; oral
36.3
14.4
18
5
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
10.5
14.2
27
26
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.9
14.0
58
154
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
24.0
13.8
19
8
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.1
13.8
74
242
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
75.7
13.6
15
*
EP1DM
NOMESCO Finland
Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet
75.7
13.6
15
*
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
14.8
13.6
22
15
R4110
NOMESCO Finland
Physiotherapy
1.6
13.6
399
2701
BA2MN
NOMESCO Finland
Thyroid radiation dose measurement during isotope therapy
+∞
13.6
13
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
13.6
13
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
13.6
13
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
13.6
13
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
13.6
13
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
13.6
13
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
34.3
13.5
17
5
ZX112
NOMESCO Finland
Subcutaneous
7.6
13.2
30
40
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.6
13.0
59
170
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.4
13.0
30
41
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
50.4
12.8
15
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
11.6
12.8
23
20
ENB50
NOMESCO Finland
Excision of cyst or fistula of thyroglossic duct
70.3
12.6
14
*
BWD00
NOMESCO Finland
Reoperation for deep haemorrhage in endocrine surgery
70.3
12.6
14
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
12.5
12
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.5
12
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
12.5
12
*
3019
Kela drug reimbursment
Lenvatinib
+∞
12.5
12
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
12.5
12
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
12.5
12
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
12.5
12
*
1508
Kela drug reimbursment
Lenvatinib
+∞
12.5
12
*
2397A
ICD-9 Finland
Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system
130.8
12.4
13
*
R13
ICD-10 Finland
Dysphagia
2.3
12.4
114
512
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.5
12.0
42
96
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
21.4
12.0
17
8
XW000
NOMESCO Finland
Bone marrow biopsy
3.5
11.9
54
156
R49.08
ICD-10 Finland
Other specified dysphonia
3.5
11.9
55
162
KCD02
NOMESCO Finland
Transurethral resection of bladder
16.5
11.7
18
11
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
2.9
11.6
72
259
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
65.4
11.6
13
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.8
11.6
227
1366
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
9.3
11.5
23
25
XX1XN
NOMESCO Finland
Other isotope examination
+∞
11.5
11
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
11.5
11
*
L01XE29
ATC
[U] lenvatinib; oral
+∞
11.5
11
*
JN5AN
NOMESCO Finland
Total body isotope imaging
+∞
11.5
11
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
11.5
11
*
2410A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic uninodular goitre
11.9
11.3
20
17
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
35.2
11.3
14
*
BA2AT
NOMESCO Finland
Biopsy of thyroid with ultrasound quidance
35.2
11.3
14
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
11.3
83
333
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
11.2
11.0
20
18
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
11.0
98
433
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
15.6
10.8
17
11
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.1
10.8
33
66
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
28.2
10.7
14
5
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
10.7
130
663
R4130
NOMESCO Finland
Speech therapy
3.8
10.6
43
114
SPAT1153
SPAT
Removal of sutures
1.5
10.5
476
3534
C90.0
ICD-10 Finland
Multiple myeloma
110.6
10.4
11
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
10.4
10
*
L02BX02
ATC
degarelix; parenteral
+∞
10.4
10
*
1CD02
NOMESCO Finland
NA
+∞
10.4
10
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
10.4
10
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
2.9
10.3
60
208
E03
ICD-10 Finland
Other hypothyroidism
2.0
10.3
123
623
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
18.9
10.3
15
8
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
9.6
10.3
20
21
ZZF00
NOMESCO Finland
Graft of adipose tissue
11.3
10.1
18
16
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
10.0
235
1492
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.1
9.8
117
589
ZX120
NOMESCO Finland
Intravenous
2.1
9.6
111
555
J01DB01
ATC
cefalexin; oral
1.4
9.5
1387
12599
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
15.1
9.5
15
10
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
7.2
9.5
22
31
Z2221
NOMESCO Finland
Medical doctor
1.5
9.5
439
3262
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
100.5
9.4
10
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
100.5
9.4
10
*
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
17.6
9.4
14
8
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.2
9.4
28
55
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
9.4
9
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
9.4
9
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
9.4
9
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
9.4
9
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
9.4
9
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
9.4
9
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
9.4
9
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
9.4
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
9.4
9
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
9.4
9
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
21.8
9.3
13
6
Z3231
NOMESCO Finland
Registered nurse
1.5
9.3
392
2856
2419X
ICD-9 Finland
Non-toxic nodular goitre, Unspecified non-toxic nodular goitre
8.7
9.3
19
22
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
9.3
121
631
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
4.7
9.2
30
65
RL210
NOMESCO Finland
NA
7.3
9.2
21
29
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
9.2
114
585
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
1.8
9.1
170
1005
E83.50
ICD-10 Finland
Hypercalcemia
4.7
9.0
29
62
H03BB01
ATC
carbimazole; oral
2.3
9.0
83
374
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
18.7
8.9
13
7
4701
FHL
Neck lymph node removal
12.6
8.9
15
12
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
8.7
173
1044
B01AB10
ATC
tinzaparin; parenteral
2.3
8.7
79
356
A06AH03
ATC
naloxegol; oral
14.1
8.7
14
10
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
8.6
106
543
UDQ02
NOMESCO Finland
Direct laryngoscopy
5.8
8.6
23
40
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.9
8.5
33
85
S77
ICPC
Malignant neoplasm of skin
27.6
8.5
11
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
90.4
8.4
9
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
90.4
8.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
90.4
8.4
9
*
L02BB03
ATC
bicalutamide; oral
90.4
8.4
9
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
8.3
8
*
D09.3
ICD-10 Finland
Carcinoma in situ: Thyroid and other endocrine glands
+∞
8.3
8
*
2509
FHL
Other measure in this category
+∞
8.3
8
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
8.3
8
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
8.3
8
*
L01CA04
ATC
vinorelbine; systemic
+∞
8.3
8
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
8.3
8
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
8.3
8
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
8.3
8
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
8.3
8
*
GBB00
NOMESCO Finland
Tracheostomy
6.2
8.3
21
34
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
3.5
8.3
37
108
L02AE02
ATC
leuprorelin; implant, parenteral
4.2
8.3
30
73
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
9.5
8.3
16
17
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
8.2
85
404
A02BC05
ATC
esomeprazole; systemic
1.4
8.1
667
5459
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
4.2
8.1
29
70
HAE99
NOMESCO Finland
Other reconstruction of breast
17.2
8.1
12
7
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
17.2
8.1
12
7
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
8.0
108
574
C08CA01
ATC
amlodipine; oral
1.4
8.0
500
3911
WW500
NOMESCO Finland
Blood transfusion
3.1
8.0
42
139
D25.1
ICD-10 Finland
Intramural leiomyoma of uterus
1.9
8.0
115
627
R50.9
ICD-10 Finland
Fever, unspecified
1.7
7.9
172
1068
HAB99
NOMESCO Finland
Other partial excision of mammary gland
4.9
7.9
24
49
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
7.8
7.9
17
22
T85
ICPC
Hyperthyroidism/thyrotoxicosis
6.1
7.8
20
33
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
4.3
7.8
27
63
DQE20
NOMESCO Finland
Implantation of foreign material in vocal chord
45.2
7.7
9
*
2260A
ICD-9 Finland
Benign neoplasm of thyroid gland[NEOPLASMA BENIGNUM GLANDULAE THYREOIDEAE]
15.1
7.7
12
8
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.0
7.6
41
138
WX110
NOMESCO Finland
Local anesthesy
1.3
7.6
1122
9984
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
18.4
7.6
11
6
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.2
7.6
27
65
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
25.1
7.6
10
*
EP1AT
NOMESCO Finland
Punction of soft tissue of neck with ultrasound guidance
25.1
7.6
10
*
S04
ICPC
Lump/swelling localized
1.7
7.5
140
828
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
2.1
7.5
80
389
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.6
7.5
31
86
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.9
7.5
43
150
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
80.4
7.4
8
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
80.4
7.4
8
*
WX400
NOMESCO Finland
Inhalation anesthesy
2.1
7.3
77
373
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
7.3
7
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
7.3
7
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.3
7
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
7.3
7
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
7.3
7
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
7.3
7
*
L02BA03
ATC
fulvestrant; parenteral
+∞
7.3
7
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
7.3
7
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
7.3
7
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
+∞
7.3
7
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
4.5
7.3
24
54
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.2
629
5173
Q18.8
ICD-10 Finland
Other specified congenital malformations of face and neck
20.1
7.1
10
5
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
6.6
7.1
17
26
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
7.9
7.1
15
19
E21.0
ICD-10 Finland
Primary hyperparathyroidism
3.2
7.1
34
106
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.4
7.0
31
91
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
7.0
150
928
N63
ICD-10 Finland
Unspecified lump in breast
1.9
6.9
91
480
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
5.5
6.9
19
35
ZXB10
NOMESCO Finland
Medial
7.6
6.9
15
20
LCA06
NOMESCO Finland
Biopsy of endometrium
1.5
6.8
211
1431
UJC01
NOMESCO Finland
Scopy of lower throat
5.0
6.8
20
40
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
9.3
6.8
13
14
R49.09
ICD-10 Finland
Unspecified dysphonia
3.7
6.8
27
73
T73
ICPC
Neoplasm endocrine other/unspecified
40.2
6.8
8
*
BAA30
NOMESCO Finland
Excision of thyroid isthmus
16.7
6.7
10
6
ELB40
NOMESCO Finland
Partial parotidectomy
4.3
6.7
23
54
R07.0
ICD-10 Finland
Pain in throat
1.9
6.7
97
529
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
7.2
6.7
15
21
UGB02
NOMESCO Finland
Tracheoscopy
22.6
6.7
9
*
WX725
NOMESCO Finland
Noninvasive ventilation
2.1
6.6
71
344
J37.0
ICD-10 Finland
Chronic laryngitis
2.3
6.6
56
245
XKD00
NOMESCO Finland
Uroflowmetry
1.7
6.5
141
874
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.8
6.5
20
42
N84.0
ICD-10 Finland
Polyp of corpus uteri
1.7
6.5
126
759
EP1AE
SPAT
NA
3.3
6.5
30
92
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.1
6.5
32
103
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
70.1
6.4
7
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
70.1
6.4
7
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
70.1
6.4
7
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
70.1
6.4
7
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
14.4
6.4
10
7
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.0
6.4
76
387
A02BC02
ATC
pantoprazole; systemic
1.3
6.4
1030
9167
B01AB04
ATC
dalteparin; parenteral
2.1
6.3
69
337
UDC00
NOMESCO Finland
Ear microscopy
1.8
6.3
103
589
ZZR10
NOMESCO Finland
Flap of skin and muscle
18.1
6.3
9
5
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
18.1
6.3
9
5
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
6.3
6
*
L01EX08
ATC
lenvatinib; oral
+∞
6.3
6
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
+∞
6.3
6
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
C75
ICD-10 Finland
Malignant neoplasm of other endocrine glands and related structures
+∞
6.3
6
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
+∞
6.3
6
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
6.3
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
6.3
6
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
4707
FHL
Dissection Colli radicalis
+∞
6.3
6
*
C73.93
ICD-10 Finland
Anaplastic thyroid carcinoma (thyroid)
+∞
6.3
6
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
6.3
6
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
6.3
6
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
6.3
6
*
C75.0
ICD-10 Finland
Malignant neoplasm: Parathyroid gland
+∞
6.3
6
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
6.3
6
*
WX734
NOMESCO Finland
JET-ventilation
26.8
6.2
8
*
GAB20
NOMESCO Finland
Median sternotomy
26.8
6.2
8
*
ZZR00
NOMESCO Finland
Flap of skin
6.3
6.2
15
24
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
6.1
96
540
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.7
6.1
13
17
H02AB09
ATC
hydrocortisone; systemic
2.8
6.1
36
130
M05BX04
ATC
denosumab; parenteral
2.1
6.1
61
291
KAC10
NOMESCO Finland
Total nephrectomy with capsule
12.6
6.1
10
8
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
12.6
6.1
10
8
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
1.9
6.0
84
454
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
6.0
70
355
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
10.0
6.0
11
11
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
6.0
199
1373
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
702
1519
6.04
323.01
3.4
3.6
ng/l
48.2
84.5
36.65
634
1307
(4035726)
512
638
9.84
307.65
1.5
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2007
9400
6.82
307.65
12.3
5.4
mmol/l
1.2
1.2
41.87
1716
7947
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
574
314
23.45
307.65
1.6
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
1476
5490
5.14
307.65
8.5
3.2
ph
7.4
7.4
1.43
295
918
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1535
1388
27.18
307.65
7.3
3.0
pmol/l
4.5
4.5
0.20
1491
1220
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
1834
21
3301.04
307.65
7.6
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
1814
104
637.74
307.65
7.9
1.1
u/ml
57.9
153.7
0.75
681
30
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1846
8457
5.56
307.65
10.3
5.0
mmol/l
1.2
1.2
31.08
1775
7509
(3015377) Calcium [Moles/volume] in Serum or Plasma
1352
6207
3.57
213.37
4.1
2.0
mmol/l
2.3
2.4
37.10
1234
5244
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2387
17183
10.15
174.53
11.6
4.2
pmol/l
17.8
14.7
307.65
2330
15800
(3002256) Pathology report gross observation
534
1788
3.53
129.99
1.4
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1490
8937
2.66
120.73
2.9
2.3
nmol/l
78.8
78.3
0.30
1412
8014
(40768804) Tissue Pathology biopsy report
1309
7432
2.60
117.97
2.5
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1070
5552
2.62
115.79
2.3
2.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
638
2611
2.94
108.83
3.6
2.6
mmol/l
0.8
0.8
1.50
608
2399
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1417
8627
2.49
106.05
4.1
3.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1272
7838
2.27
86.28
5.3
3.8
g/l
36.5
36.2
1.34
1203
7190
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
705
3370
2.52
85.90
3.7
2.1
mmol/l
2.4
2.4
13.49
636
2876
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2401
20039
6.37
85.14
15.3
5.0
mu/l
1.6
2.0
1.83
2318
18534
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
177
381
4.92
77.41
2.6
2.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1993
15238
2.54
75.84
9.5
5.5
u/l
75.1
74.5
0.35
1928
14120
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
785
4240
2.24
70.09
2.2
2.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
376
1448
2.88
69.19
7.8
2.8
mmol/l
1.2
1.2
12.58
350
1203
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1363
9321
2.02
62.99
7.1
3.8
umol/l
11.0
10.9
0.04
1305
8685
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
280
964
3.15
62.59
3.8
1.5
ug/l
9.3
16.1
0.22
206
721
(3013650) Neutrophils [#/volume] in Blood by Automated count
1532
10971
2.03
61.54
9.4
6.7
e9/l
3.9
4.1
3.74
1342
9491
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
177
496
3.76
54.52
2.3
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
462
2229
2.32
52.20
5.6
5.3
mmol/l
1.1
1.0
3.79
430
2057
(40768795) Lymph node Pathology biopsy report
51
43
12.09
50.65
1.2
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
761
4631
1.93
45.58
3.8
3.3
%
94.9
93.3
1.21
747
4489
(3013826) Glucose [Moles/volume] in Serum or Plasma
1493
11378
1.78
41.22
5.2
4.1
mmol/l
6.5
6.6
1.58
1420
10487
(40768793) Breast Pathology biopsy report
82
186
4.52
33.51
1.3
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
998
7153
1.66
31.35
7.7
8.3
inr
1.2
1.2
1.84
309
2113
(3019550) Sodium [Moles/volume] in Serum or Plasma
2356
21614
2.64
28.24
18.0
12.9
mmol/l
139.8
139.8
0.65
2323
21040
(3044889) 12 lead EKG panel
1739
14564
1.64
27.27
4.1
3.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2358
21695
2.60
27.09
18.3
13.0
mmol/l
3.9
4.0
20.84
2314
21077
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
111
363
3.15
26.77
3.2
2.0
u/ml
708.9
90.7
0.84
92
286
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
29
28
10.47
26.25
1.2
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
684
4642
1.65
25.45
7.0
4.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
187
822
2.38
25.41
9.5
11.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
331
1820
1.94
25.27
7.9
7.6
mmol/l
1.2
1.3
0.21
266
1393
(42870588) Differential panel, method unspecified - Blood
890
6458
1.59
25.09
6.1
5.7
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
331
1844
1.92
24.25
7.9
7.5
kpa
12.6
12.0
1.16
313
1763
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
331
1844
1.92
24.25
8.0
7.5
kpa
5.1
5.1
0.22
313
1764
(3002385) Erythrocyte distribution width [Ratio]
1995
17495
1.70
24.22
21.9
13.5
%
13.5
13.6
1.04
1978
17073
(3016502) Oxygen saturation in Arterial blood
301
1631
1.96
23.92
8.1
8.0
%
95.6
95.3
0.27
289
1573
(3002030) Lymphocytes/100 leukocytes in Blood
1219
9585
1.53
23.52
6.3
5.9
%
28.0
28.9
2.04
1144
8888
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2287
20964
2.10
23.28
17.1
11.2
mg/l
18.7
20.6
2.47
1894
16002
(3019069) Monocytes/100 leukocytes in Blood
1188
9315
1.53
23.06
6.5
6.1
%
8.5
8.4
0.46
1123
8675
(3006504) Eosinophils/100 leukocytes in Blood
1180
9259
1.52
22.69
6.3
5.8
%
2.8
2.9
1.30
1113
8573
(3019198) Lymphocytes [#/volume] in Blood
1286
10292
1.52
22.41
6.0
5.7
e9/l
1.9
1.9
0.11
1134
9100
(3022096) Basophils/100 leukocytes in Blood
1145
8968
1.51
21.96
6.3
5.9
%
0.7
0.7
1.11
1078
8300
(3002173) Hemoglobin [Mass/volume] in Arterial blood
276
1500
1.94
21.67
8.6
8.3
g/l
123.9
122.6
0.44
266
1440
(3010838) Calcium [Moles/time] in 24 hour Urine
54
125
4.39
21.57
2.0
1.9
mmol/24h
3.8
9.2
—
6
11
(3001604) Monocytes [#/volume] in Blood
1245
9972
1.50
21.11
6.0
5.6
e9/l
0.6
0.6
0.40
1074
8645
(3006315) Basophils [#/volume] in Blood
1249
10026
1.49
20.85
6.1
5.7
e9/l
0.0
0.0
1.21
1078
8685
(3003694) ABO and Rh group [Type] in Blood
724
5186
1.56
20.74
1.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
313
1797
1.85
20.73
3.2
2.9
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
259
1409
1.94
20.23
1.9
2.1
g/l
0.2
0.2
3.74
249
1283
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
283
1590
1.88
20.04
5.5
3.1
u/l
229.4
232.2
0.17
269
1492
(3018010) Neutrophils/100 leukocytes in Blood
1190
9512
1.48
19.96
6.2
5.7
%
57.5
56.7
1.42
1120
8845
(3013115) Eosinophils [#/volume] in Blood
1282
10407
1.48
19.84
6.1
5.8
e9/l
0.2
0.2
0.22
1134
9193
(3012565) Volume of 24 hour Urine
42
85
5.01
19.72
3.1
2.0
ml
1846.1
1956.8
0.30
36
72
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
140
611
2.37
19.31
2.0
2.0
iu/l
5.2
4.6
0.26
65
226
(3047181) Lactate [Moles/volume] in Blood
127
537
2.44
18.80
5.2
7.5
mmol/l
1.3
1.2
0.23
112
467
(3019225) pH of Specimen
319
1908
1.77
18.35
9.1
3.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2352
22064
2.17
18.12
17.1
10.9
—
—
—
0
0
(3039000) Anion gap in Blood
96
361
2.73
18.07
5.6
9.4
mmol/l
11.1
11.1
0.05
88
321
(3018572) Chloride [Moles/volume] in Blood
96
362
2.72
17.98
5.6
9.4
mmol/l
105.8
104.9
1.50
88
322
(3036481) Cortisol [Moles/volume] in Serum or Plasma
309
1902
1.71
15.96
2.6
1.8
nmol/l
383.4
361.5
0.68
289
1732
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
188
999
1.95
15.68
2.1
1.5
u/ml
41.1
26.2
0.77
182
952
(3023368) Bacteria identified in Blood by Culture
586
4220
1.51
15.65
4.4
3.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2158
19880
1.64
15.42
16.8
10.0
ml/min/173m2
83.9
82.1
3.96
1901
15968
(3013707) Erythrocyte sedimentation rate by Westergren method
1787
15822
1.46
15.39
4.5
4.1
mm/h
11.7
11.2
0.66
1662
14695
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
19
6
31.89
14.80
1.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
367
2432
1.60
14.12
2.0
2.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
226
1317
1.79
14.10
9.7
8.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
186
1043
1.85
13.16
6.2
7.3
mmol/l
25.0
24.7
0.53
173
958
(3021589) Normoblasts [#/volume] in Blood
1078
8919
1.37
12.74
11.1
8.0
e9/l
0.0
0.0
0.60
894
7293
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
347
2328
1.57
12.59
2.9
2.6
%
21.6
23.6
1.69
276
1965
(3014576) Chloride [Moles/volume] in Serum or Plasma
309
2025
1.60
12.38
7.9
6.2
mmol/l
104.2
104.3
0.17
302
1980
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
133
685
1.99
12.15
4.9
6.0
%
1.7
1.6
0.62
125
639
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
816
6496
1.38
12.10
3.7
2.7
u/l
28.0
33.0
1.25
773
6161
(3031040) Bacteria [#/volume] in Urine by Automated count
1522
13356
1.36
11.98
4.6
4.2
e6/l
587.8
2193.0
1.98
19
169
(3007930) Methemoglobin/Hemoglobin.total in Blood
132
682
1.99
11.96
4.8
6.1
%
0.9
0.9
0.23
124
639
(3002032) Base excess in Venous blood by calculation
247
1544
1.67
11.95
3.3
3.4
mmol/l
2.1
2.0
0.11
199
1265
(3004789) Transferrin [Mass/volume] in Serum or Plasma
370
2561
1.52
11.61
2.8
2.4
g/l
2.4
2.4
0.04
343
2371
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
67
265
2.57
11.52
1.4
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
185
1083
1.76
11.36
4.6
5.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
829
6682
1.36
11.17
3.6
3.4
e6/l
65.2
102.3
0.81
576
4496
(3021447) Carbon dioxide [Partial pressure] in Venous blood
244
1550
1.64
11.07
3.4
3.4
kpa
5.9
5.8
0.03
237
1504
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
146
808
1.86
10.79
11.6
9.6
mmol/l
24.6
24.5
0.30
140
750
(3022948) Iron [Moles/volume] in Serum or Plasma
398
2847
1.47
10.58
2.8
2.4
umol/l
12.9
13.8
1.69
370
2621
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
100
489
2.09
10.56
2.2
3.0
—
—
—
0
0
(3036603) Volume of Urine
37
112
3.34
10.27
1.6
1.5
ml
2340.4
2033.9
—
7
16
(36304419) Bacteria [Presence] in Urine
632
4938
1.37
10.19
3.0
2.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
375
2674
1.47
10.10
3.0
2.0
s
29.9
29.6
0.47
365
2574
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
302
2069
1.52
9.88
2.3
2.2
umol/l
8.0
6.9
0.29
266
1763
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
522
3970
1.40
9.87
1.5
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
686
5472
1.35
9.60
3.2
2.9
e6/l
36.4
72.1
1.23
521
4087
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
493
3729
1.40
9.60
3.9
3.5
ng/l
105.9
463.6
5.30
362
2684
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
46
166
2.80
9.50
1.2
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
463
3473
1.41
9.45
2.5
2.5
mosm/kgh2o
524.4
532.7
0.35
396
2899
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
376
2716
1.45
9.44
2.1
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
275
1871
1.53
9.28
2.0
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
50
191
2.65
9.27
1.5
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1083
9271
1.30
9.03
3.3
2.8
ug/l
104.0
100.5
0.25
999
8605
(3009542) Hematocrit [Volume Fraction] of Blood
2067
19351
1.40
8.88
20.2
12.4
%
39.7
39.8
0.19
1505
14147
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
272
1872
1.51
8.69
2.0
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
734
6011
1.31
8.36
2.9
3.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
606
4830
1.34
8.35
2.5
2.2
mg/l
2.9
2.9
0.07
518
4113
(3014111) Lactate [Moles/volume] in Serum or Plasma
216
1431
1.56
8.22
9.1
6.6
mmol/l
1.3
1.3
0.52
206
1387
(40760888) Immunoglobulin light chains.free panel - Serum
74
357
2.11
8.17
4.3
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
627
5047
1.32
8.02
3.1
2.8
e6/l
0.4
0.4
0.12
474
3712
(3037756) Immunofixation for Serum or Plasma
65
302
2.18
7.90
2.1
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
211
1413
1.54
7.65
3.9
2.3
g/l
10.9
10.6
0.31
193
1297
(3022145) Colonoscopy Study observation
300
2164
1.44
7.53
1.4
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
41
160
2.59
7.36
1.2
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
134
814
1.68
7.28
2.9
2.9
mmol/l
26.2
25.4
1.88
129
784
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
185
1218
1.56
7.25
1.7
1.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
15
30
5.02
7.18
1.4
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
302
2200
1.42
7.18
1.7
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
740
6170
1.28
7.14
2.6
2.3
u/l
54.3
57.4
1.78
685
5656
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
235
1644
1.47
6.92
1.2
1.2
iu/ml
161.1
150.0
0.14
88
655
(3000963) Hemoglobin [Mass/volume] in Blood
2422
23612
1.90
6.81
27.0
16.9
g/l
135.4
135.5
0.19
2404
23262
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
367
2788
1.37
6.81
2.9
2.6
e6/l
4.6
3.7
0.45
193
1432
(3024731) MCV [Entitic volume]
2421
23601
1.89
6.78
26.8
16.7
fl
90.0
90.9
22.23
2403
23250
(3007461) Platelets [#/volume] in Blood
2420
23589
1.88
6.77
26.9
16.8
e9/l
258.9
258.3
0.21
2387
22963
(3035941) MCH [Entitic mass]
2421
23602
1.89
6.76
26.7
16.7
pg
29.9
30.2
16.36
2403
23249
(3026361) Erythrocytes [#/volume] in Blood
2421
23605
1.89
6.72
26.8
16.8
e12/l
4.5
4.5
5.62
2383
22901
(3010813) Leukocytes [#/volume] in Blood
2421
23608
1.88
6.67
26.9
16.8
e9/l
6.5
6.6
1.28
2385
22903
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
72
372
1.96
6.66
3.6
3.6
%
57.3
56.8
0.12
72
372
(3042111) Morphology [Interpretation] in Bone marrow Narrative
46
200
2.32
6.59
1.3
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
481
3829
1.32
6.51
2.5
2.4
e6/l
5.0
6.7
2.49
417
3298
(3011412) CD3 cells [#/volume] in Blood
33
123
2.71
6.51
2.5
2.2
e9/l
1.1
1.2
0.17
21
70
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
61
300
2.06
6.47
1.3
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
395
3062
1.34
6.42
2.8
2.4
e6/l
0.8
1.3
1.89
217
1700
(3020779) Urea [Moles/volume] in Serum or Plasma
199
1369
1.49
6.38
9.3
7.5
mmol/l
9.5
9.3
0.10
185
1309
(40768800) Prostate Pathology biopsy report
20
56
3.59
6.31
1.2
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
6
0
+∞
6.25
1.3
0.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
89
504
1.79
6.23
4.7
1.5
mg/l
41.3
39.4
0.15
72
407
(3045142) Bone marrow Pathology biopsy report
33
126
2.64
6.22
1.2
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
58
285
2.06
6.18
4.8
5.6
iu/ml
1383.9
361.2
—
8
40
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
215
1513
1.46
6.16
3.9
2.9
ng/l
175.8
163.2
0.18
196
1374
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
88
504
1.77
5.95
4.8
1.5
mg/l
27.9
42.4
0.67
71
406
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
16
40
4.02
5.89
3.5
2.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
56
277
2.05
5.88
1.5
1.4
mu/l
35.5
44.1
0.27
46
248
(3052851) Hemolysis interference index of Serum or Plasma
91
529
1.75
5.85
3.2
3.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
55
274
2.03
5.68
1.7
1.4
nmol/l
0.3
0.4
1.60
46
229
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
79
447
1.79
5.58
1.8
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
511
4184
1.28
5.51
1.7
1.3
g/l
2.2
2.3
0.82
322
2507
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
77
435
1.79
5.48
2.8
4.1
u/ml
0.3
0.4
0.53
44
255
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
236
1728
1.40
5.46
2.6
2.2
u/l
31.1
38.1
1.45
199
1453
(3042631) Mycobacterium sp identified in Specimen
41
186
2.22
5.38
3.8
3.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
194
1375
1.45
5.37
3.3
1.5
g/l
67.2
67.4
0.19
180
1237
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
26
95
2.76
5.36
1.4
1.8
%
17.0
13.4
0.69
11
45
(3013512) EKG study
675
5732
1.24
5.31
3.5
3.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
57
296
1.95
5.27
1.3
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1510
13915
1.22
5.25
3.2
2.9
u/l
42.1
41.4
0.15
1410
12951
(40761536) Microorganisms panel - Urine sediment
223
1628
1.41
5.25
3.7
3.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
549
4559
1.26
5.25
2.2
1.8
mg/l
1.2
1.0
0.40
422
3421
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
61
325
1.90
5.23
1.5
1.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
122
791
1.57
5.18
3.7
3.9
mmol/l
24.1
24.3
0.28
110
706
(3028026) IgM [Mass/volume] in Serum or Plasma
160
1103
1.48
5.12
2.6
1.4
g/l
1.5
1.2
0.50
146
1015
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
61
328
1.88
5.10
1.5
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
69
388
1.80
5.01
3.4
3.2
mmol/l
25.1
25.1
0.01
62
337
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
24
88
2.74
4.94
1.4
1.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
241
1802
1.37
4.93
2.6
2.2
%
1.8
1.8
0.14
216
1593
(3037467) Urinalysis macro (dipstick) panel - Urine
1536
14228
1.21
4.87
4.5
4.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
184
1317
1.43
4.86
2.3
2.3
e9/l
72.3
71.4
0.09
133
996
(40760892) CBC W Ordered Manual Differential panel - Blood
546
4572
1.25
4.82
4.7
4.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
19
62
3.08
4.79
6.2
5.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
183
1313
1.42
4.77
2.3
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
52
3.28
4.74
1.5
3.0
—
—
—
0
0
(3017704) Immunofixation for Urine
24
91
2.65
4.65
1.6
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
59
324
1.84
4.65
2.9
2.7
kpa
8.3
8.1
0.24
53
297
(40768806) Pleura Pathology biopsy report
22
80
2.77
4.61
1.5
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
61
340
1.81
4.59
2.3
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
208
1539
1.38
4.55
4.1
4.0
%
1.7
0.7
2.79
62
288
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
104
2.52
4.54
1.7
1.5
e6/l
16940.1
106453.9
0.81
16
61
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2320
22562
1.41
4.51
12.5
8.8
u/l
24.9
25.1
0.33
2264
21725
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
131
896
1.49
4.40
2.0
2.0
u/l
36.6
39.2
0.86
117
798
(3010421) pH of Blood
72
427
1.71
4.40
5.3
3.8
ph
7.4
7.4
0.01
56
346
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
40
196
2.06
4.39
1.2
1.2
u/l
91.7
56.4
0.93
33
134
(3017446) Testosterone [Moles/volume] in Serum or Plasma
124
839
1.50
4.39
2.1
2.2
nmol/l
10.8
13.3
2.68
108
740
(3023323) Follitropin [Units/volume] in Serum or Plasma
154
1089
1.44
4.36
1.4
1.3
iu/l
31.4
29.2
0.38
136
947
(3021901) Oxygen saturation in Capillary blood
50
267
1.89
4.32
3.0
2.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
167
1202
1.42
4.30
3.1
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
39
191
2.06
4.29
4.5
3.1
%
2.8
0.9
1.31
30
144
(3002179) Metamyelocytes/100 leukocytes in Blood
192
1419
1.38
4.24
4.0
3.8
%
1.8
0.5
1.24
41
222
(3037522) Nuclear Ab [Titer] in Serum
385
3140
1.27
4.23
1.4
1.3
titre
426.7
579.6
1.41
75
681
(3021440) Promyelocytes/100 leukocytes in Blood
199
1482
1.37
4.20
4.2
4.1
%
0.3
0.1
1.23
57
265
(3024980) IgG subclass 4 [Mass/volume] in Serum
59
339
1.76
4.05
2.0
1.7
g/l
0.8
0.8
0.09
40
252
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
109
733
1.51
4.00
2.3
2.0
u/l
7147.1
3888.2
0.33
23
310
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
106
2.37
3.90
1.5
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
79
497
1.61
3.89
2.8
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1128
10289
1.18
3.87
3.7
3.6
estimate
0.0
0.0
1.32
224
1726
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
57
329
1.75
3.87
2.4
1.5
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
48
263
1.84
3.86
1.5
1.4
pmol/l
299.9
328.6
0.37
40
203
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
32
152
2.12
3.84
1.3
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
45
242
1.88
3.84
3.5
2.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
52
294
1.79
3.79
1.5
1.4
u/ml
105.7
111.3
0.19
12
53
(3012501) Base excess in Blood by calculation
59
348
1.71
3.73
5.9
4.0
mmol/l
2.8
2.6
0.14
41
225
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
80
511
1.58
3.71
2.9
2.4
%
184.0
179.4
0.18
73
485
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
76
480
1.60
3.70
4.1
2.6
g/l
3.5
3.6
0.26
70
452
(3021601) Nitrite [Presence] in Urine by Test strip
1115
10187
1.17
3.69
5.0
4.8
estimate
0.0
0.0
0.80
225
1761
(3023199) Leukocytes [#/volume] in Pleural fluid
27
122
2.23
3.67
1.6
1.5
e6/l
1610.2
3105.7
0.72
21
91
(40768797) Stomach Pathology biopsy report
353
2899
1.25
3.66
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
936
8446
1.17
3.59
2.0
1.9
pmol/l
95.6
97.9
0.65
461
4154
(3045788) Cell count panel - Pleural fluid
23
98
2.36
3.57
1.7
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
54
317
1.72
3.49
2.9
2.4
%
15.8
16.7
0.74
33
155
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
671
5902
1.19
3.48
1.8
1.6
mmol/l
1.3
1.4
2.61
564
4986
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
31
3.56
3.48
1.6
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
84
552
1.54
3.47
2.7
2.2
%
93.8
93.0
0.14
79
509
(3025159) Blasts/100 leukocytes in Blood
188
1432
1.34
3.47
4.1
4.1
%
0.2
0.4
0.27
46
242
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
56
334
1.69
3.42
1.3
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
258
2058
1.28
3.41
1.4
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
206
2631
0.76
3.41
4.6
4.6
%
32.6
32.8
0.06
142
1786
(1616796) Gas panel - Central venous blood
56
335
1.69
3.39
5.1
3.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
23
101
2.29
3.36
1.8
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
700
6198
1.18
3.34
2.3
2.1
u/l
147.1
202.7
1.58
669
5803
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
30
148
2.04
3.31
2.0
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
49
286
1.73
3.25
1.3
1.2
nmol/l
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
42
235
1.80
3.22
2.6
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
60
372
1.63
3.19
3.3
3.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
33
3.34
3.19
1.2
1.7
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
11
6.38
3.18
7.0
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1898
18194
1.18
3.12
23.6
14.7
g/l
332.2
332.0
0.29
1888
18079
(3048929) Epstein Barr virus Ab [Presence] in Serum
84
567
1.50
3.10
1.4
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
20
86
2.34
3.08
1.5
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
22
99
2.23
3.06
1.7
1.5
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
11
34
3.25
3.06
1.5
2.0
e6/l
90.0
172.4
—
6
21
(3041096) Erythrocytes [Presence] in Urine by Automated
622
5492
1.18
3.04
3.2
3.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
569
4988
1.18
3.03
1.3
1.3
u/ml
1.8
1.7
0.15
147
1356
(3035350) Ketones [Presence] in Urine by Test strip
1099
10133
1.15
3.02
3.7
3.5
estimate
0.0
0.0
0.00
225
1728
(3047189) Immunofixation for 24 hour Urine
13
45
2.90
3.02
2.7
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
20
87
2.31
3.00
1.5
1.2
—
—
—
0
0
(3036489) Thrombin time
98
688
1.44
2.98
2.5
2.0
s
21.2
20.8
0.32
85
588
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
81
548
1.49
2.97
2.4
2.1
mg/l
11.1
11.0
0.02
75
506
(3017143) Hepatitis C virus Ab [Presence] in Serum
261
2124
1.26
2.95
1.7
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
58
366
1.60
2.90
1.4
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
9
22
4.10
2.88
1.3
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
9
6.68
2.87
1.8
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
819
7429
1.15
2.78
3.3
3.4
ng/l
47.7
57.3
0.23
511
4648
(3024139) IgG subclass 3 [Mass/volume] in Serum
38
217
1.76
2.76
1.8
1.4
g/l
0.4
0.4
0.22
23
146
(3028192) IgG subclass 2 [Mass/volume] in Serum
38
217
1.76
2.76
1.8
1.4
g/l
2.7
2.8
0.06
24
145
(3048689) Calprotectin [Mass/mass] in Stool
323
2711
1.22
2.75
2.5
2.3
ug/g
105.3
116.2
0.40
250
2132
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
144
1095
1.33
2.74
2.5
2.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
23
111
2.08
2.73
1.8
2.0
%
45.8
44.7
—
5
15
(3027135) IgG subclass 1 [Mass/volume] in Serum
38
218
1.75
2.72
1.8
1.4
g/l
7.2
6.7
0.29
22
146
(4062490)
38
218
1.75
2.72
1.8
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
81
559
1.46
2.72
1.4
1.4
ug/g
329.3
313.6
0.34
47
302
(21494814) CD8 cells/100 lymphocytes in Specimen
13
48
2.72
2.71
1.3
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
21
98
2.15
2.70
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
486
4243
1.18
2.70
1.4
1.4
—
—
—
0
0
(4281824)
26
132
1.98
2.70
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
68
454
1.51
2.69
1.6
1.3
u/l
14.3
10.7
1.04
53
372
(3003327) Ova and parasites identified in Stool by Light microscopy
96
688
1.41
2.65
1.6
1.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
89
630
1.43
2.63
1.1
1.1
u/ml
2.0
4.6
0.90
13
76
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
92
656
1.42
2.61
3.0
1.4
g/l
10.0
10.4
0.38
70
550
(3024354) Oxygen [Partial pressure] in Venous blood
165
1290
1.30
2.60
3.7
2.7
kpa
4.9
4.6
0.83
157
1251
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
34
192
1.78
2.58
2.0
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
221
1800
1.25
2.51
1.2
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
578
5150
1.16
2.47
2.6
2.2
umol/l
2218.8
5038.7
1.56
508
4448
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
50
318
1.58
2.47
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
50
318
1.58
2.47
1.3
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
26
137
1.91
2.45
1.8
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
520
4599
1.17
2.45
1.5
1.5
nmol/l
21.9
21.3
0.15
461
3899
(3013139) Helicobacter pylori Ag [Presence] in Stool
189
1518
1.27
2.42
1.3
1.3
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
21
103
2.05
2.41
1.3
1.1
u/l
70.4
72.3
0.06
14
74
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
93
679
1.38
2.34
1.7
1.6
g/l
1.5
1.5
0.17
80
592
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
92
672
1.38
2.31
1.6
1.7
g/l
1.2
1.2
0.19
85
634
(3000494) Fungus identified in Specimen by Culture
281
2370
1.21
2.30
1.7
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
52
340
1.54
2.30
1.4
1.2
u/ml
309.6
237.3
1.00
31
213
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
96
707
1.37
2.30
3.0
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
90
656
1.39
2.29
1.6
1.8
g/l
0.2
0.2
1.03
83
621
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
96
708
1.37
2.28
3.0
1.4
g/l
3.8
3.8
0.02
62
503
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
96
708
1.37
2.28
3.0
1.4
g/l
7.2
7.4
0.30
65
529
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
31
178
1.75
2.26
3.6
1.7
u/ml
6.4
797.1
0.51
31
166
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
581
5213
1.15
2.25
3.0
2.9
ng/l
1128.8
1149.9
0.05
492
4369
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
73
2.20
2.21
2.4
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
68
957
0.70
2.20
2.1
1.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
34
203
1.68
2.18
1.6
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
21
108
1.95
2.15
2.3
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
176
1424
1.25
2.15
1.3
1.3
au/ml
64.5
48.3
—
10
70
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
6
14
4.29
2.15
1.3
1.0
nmol/l
0.4
0.2
—
6
7
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
42
266
1.59
2.15
1.9
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
9
30
3.01
2.14
1.1
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
16
74
2.17
2.14
1.0
1.2
%
121.8
112.0
0.70
16
65
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
30
175
1.72
2.09
1.3
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
82
2.08
2.06
2.9
2.6
%
44.4
45.3
—
5
30
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
20
103
1.95
2.05
1.3
1.1
u/l
13.6
15.7
0.19
12
70
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
190
1563
1.23
2.02
2.3
2.4
au/ml
18.2
25.2
0.71
16
93
(3017732) Neutrophils [#/volume] in Blood
180
1473
1.24
2.00
2.5
2.6
e9/l
3.9
4.1
0.31
152
1155
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
65
460
1.42
1.99
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
29
171
1.70
1.96
1.4
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
84
2.03
1.95
2.4
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
17
84
2.03
1.95
1.2
1.4
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
5
11
4.55
1.94
1.2
1.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
73
531
1.39
1.93
2.7
1.9
ug/l
2.5
1.7
0.38
60
460
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
45
2.45
1.93
1.4
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
669
1.34
1.92
3.1
1.4
g/l
3.0
3.0
0.08
65
516
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
21
113
1.87
1.91
1.5
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
104
802
1.31
1.89
1.3
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
31
189
1.65
1.87
2.6
2.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
205
1.62
1.86
1.9
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
846
7860
1.12
1.83
3.8
3.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
105
815
1.30
1.83
3.1
2.4
%
0.6
0.7
0.05
100
777
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
12
4.17
1.82
9.2
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
12
4.17
1.82
1.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
15
73
2.06
1.80
2.5
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
491
4420
1.14
1.80
1.6
1.7
pmol/l
461.9
41181665.2
4.59
390
3708
(3009508) Creatinine [Moles/volume] in Urine
695
6396
1.12
1.78
3.1
3.1
mmol/l
7.2
7.2
0.04
588
5411
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
14
67
2.10
1.76
3.5
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
14
67
2.10
1.76
3.5
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
14
67
2.10
1.76
3.5
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
14
67
2.10
1.76
3.5
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
12
54
2.23
1.74
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
161
1326
1.23
1.72
1.5
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
54
381
1.43
1.72
2.5
2.1
g/l
124.4
131.9
1.16
44
273
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
13
3.85
1.71
7.8
2.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
106
833
1.28
1.70
3.1
2.4
%
1.1
1.2
0.93
106
824
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
22
126
1.75
1.68
2.9
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
22
126
1.75
1.68
2.9
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
22
126
1.75
1.68
2.9
1.3
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
19
3.16
1.66
5.5
4.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
21
119
1.77
1.66
1.4
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
90
1.89
1.65
1.6
1.8
—
—
—
0
0
(1002224) Polysomnography panel
115
918
1.26
1.64
1.0
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
21
120
1.76
1.62
1.7
1.5
u/l
8.7
7.4
—
9
52
(3044941) Cell count panel - Synovial fluid
47
328
1.44
1.61
1.3
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
401
3591
1.14
1.60
1.7
1.7
nmol/l
1132.5
1176.8
0.44
329
2734
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
23
136
1.70
1.58
2.8
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
184
1552
1.20
1.57
3.0
2.2
ml/min/173m2
65.3
69.5
0.81
79
586
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
99
1.82
1.57
4.2
2.4
e6/l
584.9
767.5
—
9
44
(46235355) HIV 1 and 2 tests - Meaningful Use set
384
3434
1.14
1.57
1.9
1.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
173
1452
1.21
1.56
1.3
1.3
u/ml
96.3
198.5
3.22
159
1338
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1442
13844
1.10
1.55
3.3
3.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
74
562
1.33
1.54
1.3
1.2
titre
84.0
92.9
—
10
48
(3052592) Norovirus Ag [Presence] in Stool
8
33
2.43
1.53
1.5
1.3
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
5
15
3.34
1.52
7.8
2.0
mg/l
22.6
21.7
—
5
15
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
27
2.60
1.51
1.6
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
27
2.60
1.51
1.6
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
27
2.60
1.51
1.6
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
25
154
1.63
1.50
2.7
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
401
3614
1.13
1.46
5.3
3.6
ug/l
2.1
1.8
0.96
361
3236
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
28
2.50
1.45
2.3
3.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
25
156
1.61
1.43
2.1
2.4
%
10.5
11.2
0.37
25
156
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
22
2.73
1.43
1.2
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
57
423
1.36
1.41
1.5
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
67
511
1.32
1.38
1.3
1.2
u/ml
25.7
42.6
—
5
60
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
53
2.08
1.38
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
117
958
1.23
1.38
1.6
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
67
868
0.77
1.37
1.4
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
61
1.97
1.32
1.2
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
34
233
1.47
1.32
2.1
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
45
326
1.39
1.30
1.4
1.2
u/ml
5.4
5.9
0.09
22
131
(21494755) Public health laboratory ask at order entry panel
180
2086
0.85
1.29
1.3
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
132
0.45
1.28
1.3
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
22
339
0.65
1.24
1.8
1.6
—
—
—
0
0
(44790049)
26
171
1.53
1.23
1.7
1.4
—
—
—
0
0
(44790047)
26
171
1.53
1.23
1.7
1.4
—
—
—
0
0
(44806118)
26
171
1.53
1.23
1.7
1.4
—
—
—
0
0
(44790048)
26
171
1.53
1.23
1.7
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
37
2.17
1.21
1.9
2.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
36
501
0.71
1.21
2.0
2.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
45
331
1.37
1.21
1.4
1.2
u/ml
2.2
3.2
0.42
16
102
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
31
213
1.46
1.20
1.3
1.2
ug/l
1.8
2.7
1.28
26
187
(3043409) Potassium [Moles/volume] in Arterial blood
65
506
1.29
1.19
3.8
3.8
mmol/l
3.8
3.8
0.17
59
481
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
152
1298
1.18
1.19
1.7
1.8
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
75
596
1.27
1.18
3.5
1.4
g/l
0.7
0.4
0.26
61
517
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
14
79
1.78
1.17
1.2
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
43
316
1.37
1.17
1.2
1.3
mmol/l
64.5
64.9
0.02
31
256
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
74
923
0.80
1.15
1.4
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
40
292
1.38
1.13
1.4
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
121
1019
1.20
1.12
1.5
1.7
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
63
494
1.28
1.11
2.9
1.4
g/l
0.0
0.0
0.00
54
452
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
67
531
1.27
1.09
2.9
1.4
g/l
0.0
0.0
0.34
58
487
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
21
2.38
1.09
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
41
1.95
1.08
1.1
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
41
1.95
1.08
1.0
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
33
235
1.41
1.08
1.6
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
20
128
1.57
1.08
4.7
2.8
%
49.1
57.3
—
10
86
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
37
501
0.73
1.08
1.3
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
32
227
1.42
1.08
1.2
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
62
489
1.27
1.06
2.9
1.4
g/l
0.0
0.0
0.00
54
451
(3000330) Specific gravity of Urine by Test strip
84
1021
0.82
1.05
3.3
3.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
33
2.12
1.05
1.9
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
72
889
0.80
1.05
2.2
1.7
mg/l
3.6
3.8
0.07
54
618
(3044290) Cell count panel - Cerebral spinal fluid
53
410
1.30
1.05
1.4
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
114
962
1.19
1.05
1.4
1.3
u/ml
2.8
1.0
—
10
81
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
312
2833
1.12
1.04
1.7
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
44
332
1.33
1.03
1.9
2.9
umol/l
24.7
35.7
2.80
38
291
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
46
1.96
1.03
5.7
2.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
141
1214
1.17
1.03
1.2
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
28
196
1.43
1.02
2.1
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
47
1.92
1.02
1.4
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
319
2904
1.11
1.02
4.4
3.6
%
22.6
23.7
0.65
166
1268
(3021788) Differential panel - Synovial fluid
50
386
1.30
1.01
1.6
1.5
—
—
—
0
0
(3020891) Body temperature
84
692
1.22
1.00
4.8
4.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
132
0.53
0.98
11.6
17.7
nmol/l
987.7
1500.9
—
7
127
(3012516) Albumin [Mass/volume] in Urine
637
6000
1.08
0.98
3.2
3.2
mg/l
1130.2
319.7
1.72
380
3583
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
49
1.84
0.98
4.8
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
49
1.84
0.98
4.8
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
49
1.84
0.98
4.8
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
26
366
0.71
0.97
1.7
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
21
140
1.50
0.97
1.7
2.4
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
2.3
—
44.2
—
0
24
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
59
469
1.26
0.96
1.5
1.3
e6/l
52.6
30.2
0.39
34
367
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
50
1.80
0.96
1.1
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
50
1.80
0.96
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
18
116
1.56
0.96
1.1
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
59
470
1.26
0.95
1.5
1.4
e6/l
1199.8
1468.4
0.10
40
387
(4268621)
31
225
1.38
0.94
2.2
2.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
70
1.72
0.92
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
72
590
1.23
0.92
3.9
2.6
g/l
0.2
0.3
2.07
33
181
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
14
86
1.63
0.91
3.6
1.8
ug/l
22.1
110.0
0.47
14
77
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
14
86
1.63
0.91
4.1
1.6
u/l
194.8
190.3
0.11
14
86
(3006922) Hepatitis E virus Ab [Presence] in Serum
18
118
1.53
0.90
1.0
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
6
29
2.07
0.89
1.5
1.9
g/l
13.7
10.0
—
6
20
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
42
1.91
0.88
1.1
1.5
ng/l
51.1
105.9
—
8
42
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
25
177
1.42
0.88
1.1
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
129
0.54
0.88
9.1
12.8
nmol/l
569.0
826.7
—
7
124
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
41
317
1.30
0.85
1.1
1.0
u/ml
2.1
2.2
0.05
25
145
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
31
230
1.35
0.85
1.7
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
31
230
1.35
0.85
1.7
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
112
1.52
0.85
1.0
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
122
1059
1.16
0.84
3.6
3.4
kpa
5.2
5.2
0.10
111
981
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
113
976
1.17
0.83
1.6
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
44
556
0.79
0.83
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
226
2047
1.11
0.82
3.0
2.6
ug/l
0.7
0.7
0.30
160
1284
(40768446) Kidney Pathology biopsy report
11
65
1.70
0.82
1.6
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
113
1.51
0.82
1.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
105
1.53
0.81
1.3
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
73
1.65
0.81
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
120
1044
1.16
0.81
3.6
3.4
ph
7.4
7.4
0.12
24
115
(3024932) HLA-DR beta [Type]
8
47
1.70
0.80
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
42
330
1.28
0.79
1.3
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
68
565
1.21
0.79
3.0
1.4
g/l
38.7
38.2
0.36
57
478
(3024471) HLA-A [Type]
8
48
1.67
0.78
1.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
8
48
1.67
0.78
1.4
1.2
mu/l
57.4
57.8
—
8
38
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
96
0.52
0.78
1.0
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
86
732
1.18
0.77
1.7
1.7
mu/l
328.1
309.4
0.20
80
651
(3029396) Erythrocyte agglutination [Presence] in Blood
6
34
1.77
0.76
1.2
3.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
34
1.77
0.76
3.5
2.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
60
495
1.22
0.75
1.7
1.6
e6/l
13936.0
11533.7
0.20
48
361
(3024891) Influenza virus A+B Ag [Presence] in Specimen
62
514
1.21
0.74
1.1
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
24
2.09
0.74
2.2
1.7
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
5
24
2.09
0.74
1.8
1.5
—
—
—
0
0
(4146454)
15
220
0.68
0.74
2.6
2.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
195
0.66
0.72
1.3
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
71
599
1.19
0.72
1.2
1.3
—
—
—
0
0
(4198724)
11
68
1.62
0.71
2.6
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
565
5365
1.07
0.71
4.2
4.0
estimate
0.0
0.0
1.08
217
1753
(3023410) Appearance of Cerebral spinal fluid
27
203
1.33
0.70
1.6
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
661
6311
1.06
0.70
4.0
3.9
mg/mmol
8.7
7.9
0.15
392
3807
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
25
186
1.35
0.70
1.2
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
183
2016
0.90
0.69
1.9
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
135
1.41
0.69
7.6
3.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
25
187
1.34
0.68
1.3
1.2
u/ml
0.2
1.0
0.70
14
82
(3044927) Protein electrophoresis panel - Urine
27
205
1.32
0.67
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
71
604
1.18
0.67
1.4
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
7
43
1.63
0.66
1.0
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
114
1007
1.14
0.66
3.6
3.3
mmol/l
2.7
1.7
2.40
90
754
(3024869) Neuronal Ab [Presence] in Serum
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1995
19683
1.07
0.66
5.9
5.6
mmol/mol
39.2
39.4
0.50
1869
18338
(3051611) Lipemic interference index of Serum or Plasma
23
171
1.35
0.65
5.9
3.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
11
70
1.57
0.65
1.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2119
21417
0.93
0.65
4.5
4.4
mmol/l
4.7
4.8
1.39
1995
20006
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2154
21757
0.93
0.64
5.0
4.9
mmol/l
2.8
2.8
0.07
2011
20207
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
29
1.73
0.64
3.2
2.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
49
405
1.21
0.63
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
209
2273
0.91
0.62
1.9
1.9
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
71
609
1.17
0.62
1.4
1.3
u/ml
3.4
6.4
—
10
102
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2106
21283
0.93
0.62
4.4
4.4
mmol/l
1.5
1.5
4.44
1968
19768
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
132
1184
1.12
0.61
1.1
1.0
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
30
1.67
0.61
1.4
1.2
%
42.4
43.5
—
5
25
(3042733) HLA Ab [Presence] in Serum
8
51
1.57
0.60
4.6
4.7
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
25.5
—
0
6
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2030
20533
0.94
0.59
3.9
3.9
mmol/l
1.3
1.3
0.38
1880
18919
(3019150) Specific gravity of Urine by Refractometry
479
4554
1.06
0.59
4.3
4.0
kg/l
1.0
1.0
0.10
84
649
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
52
1.54
0.59
1.4
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
19
140
1.36
0.58
1.3
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
149
1640
0.90
0.58
3.9
3.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
35
1.72
0.57
1.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
35
283
1.24
0.56
1.2
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
38
462
0.82
0.56
1.3
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
83
728
1.14
0.56
1.6
2.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
39
320
1.22
0.56
1.2
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
37
1.62
0.55
1.2
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
38
461
0.82
0.55
1.3
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
30
239
1.26
0.55
1.2
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
41
339
1.21
0.55
1.2
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
95
843
1.13
0.54
1.7
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
38
460
0.82
0.54
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
38
460
0.82
0.54
1.3
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
19
142
1.34
0.54
1.3
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
28
222
1.26
0.54
1.8
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
21
160
1.32
0.53
1.5
2.2
u/field
0.7
2.3
—
9
72
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
74
1.49
0.53
1.2
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
69
600
1.15
0.53
1.4
1.2
u/ml
1.4
7.8
—
8
58
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
123
1359
0.90
0.53
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
28
223
1.26
0.52
1.8
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
16
117
1.37
0.52
1.3
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
134
0.67
0.51
1.2
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
41
342
1.20
0.51
1.2
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
37
306
1.21
0.50
1.1
1.1
%
125.7
117.2
0.77
32
276
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
13
179
0.72
0.50
1.2
1.4
nmol/l
1.4
1.5
0.10
13
162
(3010726) Horse dander IgE Ab [Units/volume] in Serum
40
334
1.20
0.50
1.1
1.1
u/ml
0.1
2.1
—
7
87
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
102
916
1.12
0.50
1.3
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
226
2419
0.93
0.49
1.5
1.7
%
1.4
1.4
0.28
195
2136
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
67
1.49
0.49
1.7
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
67
1.49
0.49
1.7
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
28
225
1.25
0.49
1.8
1.4
—
—
—
0
0
(3000492) Spirometry study
215
2005
1.08
0.48
1.5
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
504
4835
1.05
0.47
3.9
3.6
—
—
—
0
0
(3000012) Reticulocyte production index
12
85
1.41
0.47
1.4
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
7
48
1.46
0.46
4.6
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
43
365
1.18
0.46
1.2
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
49
1.43
0.46
1.4
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
49
1.43
0.46
1.4
2.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
81
0.62
0.45
1.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
36
428
0.84
0.45
1.4
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
77
685
1.13
0.45
1.6
1.6
iu/ml
0.5
0.2
0.32
19
135
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
95
1.37
0.43
1.7
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
40
469
0.85
0.43
2.0
3.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
20
157
1.28
0.43
1.2
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
9
128
0.70
0.43
1.4
1.4
—
647.3
—
0
11
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
21
166
1.27
0.43
5.0
4.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
15
113
1.33
0.42
1.3
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
79
708
1.12
0.42
2.5
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
70
1.43
0.41
1.4
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
70
1.43
0.41
1.4
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
13
96
1.36
0.41
2.2
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
38
323
1.18
0.41
3.3
3.1
nmol/l
0.8
0.8
0.22
31
241
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
62
548
1.13
0.41
1.4
1.4
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
2.4
—
0
8
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.0
—
0
9
(3050794) Legionella sp Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
241
2551
0.94
0.41
7.5
6.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
59
1.36
0.41
1.3
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
17
0.00
0.40
0.0
2.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
34
401
0.85
0.40
1.3
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
0.0
—
0
10
(3004616) Nuclear Ab [Presence] in Serum
33
278
1.19
0.40
1.5
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
97
1.34
0.39
1.3
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
33
389
0.85
0.39
1.3
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
31
260
1.19
0.39
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
83
750
1.11
0.39
1.9
1.9
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.8
—
44.1
—
0
19
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
0.3
—
0
13
(3014765) Yersinia sp identified in Stool by Organism specific culture
70
627
1.12
0.38
1.2
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
23
280
0.82
0.38
1.1
1.1
u/ml
0.6
3.5
—
7
114
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
36
1.39
0.38
1.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
33
387
0.85
0.37
1.3
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
23
188
1.23
0.37
2.6
1.6
pg
33.0
32.4
0.31
23
188
(3051651) Icteric interference index of Serum or Plasma
11
81
1.36
0.36
8.5
4.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
79
0.63
0.35
1.8
2.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
44
1.36
0.34
1.0
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
13
167
0.78
0.34
1.3
1.4
mmol/l
9.7
11.8
—
5
41
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
178
0.79
0.34
1.4
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
65
586
1.11
0.33
1.2
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
18
145
1.24
0.33
2.1
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
26
307
0.85
0.33
1.4
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
86
0.70
0.33
1.2
8.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
70
635
1.11
0.33
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
69
626
1.11
0.32
1.2
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
73
665
1.10
0.32
1.4
1.3
miu/ml
240.8
216.6
0.21
35
330
(3004716) Salmonella sp identified in Stool by Organism specific culture
106
1142
0.93
0.32
1.5
1.4
—
—
—
0
0
(4027681)
16
128
1.25
0.32
1.3
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
46
408
1.13
0.31
2.2
2.1
nmol/l
0.9
0.8
0.41
36
336
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
21
251
0.84
0.31
1.0
1.1
u/ml
0.2
0.3
—
5
65
(3009871) Measles virus Ab [Titer] in Serum
10
75
1.33
0.30
1.9
1.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
31
269
1.15
0.29
1.8
1.5
%
67.6
59.6
0.55
18
167
(44816559) Phosphatidylethanol [Mass/volume] in Blood
35
398
0.88
0.29
1.7
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
149
1.21
0.27
1.1
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
71
653
1.09
0.27
2.0
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
26
224
1.16
0.27
1.7
2.3
mg/l
38.8
26.0
—
9
59
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
71
0.70
0.26
1.0
1.5
ug/l
6.7
8.8
—
5
71
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
96
1.25
0.24
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
244
0.86
0.24
1.3
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
17
143
1.19
0.23
1.4
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
38
1.32
0.23
1.0
1.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
39
1.28
0.23
1.2
1.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
91
0.77
0.22
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
11
0.00
0.21
0.0
4.8
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
14.8
—
0
10
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
10
0.00
0.21
0.0
4.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
45
411
1.10
0.21
1.0
1.1
u/ml
1.3
1.5
0.17
24
163
(3003888) Timothy IgE Ab [Units/volume] in Serum
40
363
1.10
0.21
1.1
1.1
u/ml
3.6
4.8
0.41
26
189
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
2.4
—
4.1
—
0
12
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
12
0.00
0.21
0.0
1.6
—
2.7
—
0
12
(3026480) Teichoate Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.1
—
0
7
(3018001) Oat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.1
—
0
7
(3007542) Rye IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.2
—
0
7
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
103
0.78
0.21
1.1
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
770
7826
0.98
0.21
2.8
2.8
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
15
126
1.19
0.21
1.0
1.0
u/ml
0.3
0.9
—
8
44
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
24.4
—
0
5
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
40
364
1.10
0.20
2.1
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
49
1.23
0.20
1.0
1.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
51
1.18
0.19
1.2
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
145
1390
1.05
0.19
3.2
2.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
81
1.24
0.18
1.3
1.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
27
301
0.90
0.18
1.6
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
87
823
1.06
0.18
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
100
1.20
0.18
1.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
147
1.16
0.18
3.0
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
238
2309
1.03
0.18
19.7
23.1
inr
1.2
1.3
0.53
43
348
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
51
474
1.08
0.17
1.3
1.2
u/ml
16.9
3.7
—
7
35
(3029075) Extractable nuclear Ab panel - Serum
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
15
129
1.16
0.17
1.1
1.1
u/l
0.9
1.1
—
7
66
(3014599) Egg white IgE Ab [Units/volume] in Serum
10
120
0.83
0.16
1.1
1.0
u/ml
0.3
0.5
—
5
30
(3014133) Dog dander IgE Ab [Units/volume] in Serum
28
308
0.91
0.16
1.0
1.1
u/ml
1.9
2.7
—
9
116
(3014271) Vancomycin [Susceptibility]
6
80
0.75
0.15
2.8
2.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2099
20912
1.02
0.15
4.8
4.5
mmol/l
5.9
5.9
0.74
1953
19217
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
197
1.12
0.15
2.2
2.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
22
244
0.90
0.14
1.1
2.0
umol/l
3.9
4.7
0.45
13
171
(21494434) Karyotype in Bone marrow
15
131
1.15
0.14
1.1
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
12
103
1.17
0.13
1.4
1.4
pmol/l
147.1
339.6
—
7
32
(3024263) Appearance of Synovial fluid
8
100
0.80
0.13
2.1
1.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
13
113
1.15
0.13
1.1
1.4
nmol/l
123.2
137.0
1.31
13
113
(3019420) Tryptase [Mass/volume] in Serum or Plasma
13
113
1.15
0.13
1.6
1.5
ug/l
7.2
8.0
0.15
13
92
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
35
326
1.07
0.12
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
85
1.18
0.12
1.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
404
3976
1.02
0.12
1.3
1.3
u/ml
16.3
11.6
0.51
150
1591
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
33
307
1.08
0.12
1.6
1.4
u/l
36.0
28.4
0.45
25
240
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
410
4164
0.98
0.12
1.3
1.3
iu/ml
40.1
34.2
0.23
132
1316
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
196
2008
0.97
0.12
1.7
1.7
—
—
—
0
0
(4306422)
35
327
1.07
0.11
1.2
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
95
1.16
0.11
1.1
1.1
—
—
—
0
0
(4034850)
75
720
1.04
0.11
13.0
8.9
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
37
349
1.06
0.10
1.0
1.1
u/ml
0.8
1.0
0.15
24
147
(3029634) Reagin Ab [Titer] in Serum by VDRL
29
271
1.07
0.09
1.5
1.9
—
4.0
—
0
6
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
18
164
1.10
0.09
1.8
1.1
—
—
—
0
0
(4010399)
150
1535
0.98
0.09
1.4
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
17
186
0.91
0.09
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
17
186
0.91
0.09
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
17
186
0.91
0.09
1.3
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
124
0.89
0.09
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
35
331
1.06
0.08
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
56
1.07
0.08
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
17
185
0.92
0.08
1.3
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
44
460
0.96
0.08
3.8
4.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
21
195
1.08
0.08
1.9
1.4
%
33.2
34.7
0.06
11
119
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
66
1.06
0.08
1.1
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22
205
1.07
0.08
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
76
1.05
0.07
1.4
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
17
184
0.92
0.07
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
17
184
0.92
0.07
1.3
1.1
—
—
—
0
0
(4211845)
12
108
1.11
0.07
2.1
3.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
83
0.84
0.07
1.4
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
34
324
1.05
0.07
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
163
1602
1.02
0.06
2.0
2.3
ug/l
8.0
7.1
0.15
140
1405
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
90
0.89
0.06
2.5
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
92
0.87
0.06
1.1
1.1
miu/ml
2044.0
1726.7
—
8
92
(40757494) Bilirubin.total [Moles/volume] in Blood
11
99
1.11
0.06
2.5
1.7
—
17.6
—
0
9
(3017315) Amylase [Enzymatic activity/volume] in Urine
10
111
0.90
0.06
1.0
1.2
u/l
189.2
346.1
—
10
99
(3022313) Gas panel - Capillary blood
80
781
1.03
0.05
3.6
3.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
14
151
0.93
0.05
1.6
1.4
—
1.5
—
0
8
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
17
181
0.94
0.05
1.5
1.5
g/l
1.0
1.0
0.01
17
181
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
13
120
1.08
0.05
1.2
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
91
1.10
0.04
1.6
1.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
45
438
1.03
0.03
2.9
3.6
mg/l
35.7
23.7
0.66
24
276
(3016879) Cocaine [Presence] in Urine
61
623
0.98
0.03
1.7
2.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
22
229
0.96
0.03
1.4
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
23
239
0.96
0.02
1.5
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
67
680
0.98
0.02
1.7
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
46
469
0.98
0.02
2.8
2.3
ug/min
129.0
104.3
0.11
27
291
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
103
1.07
0.02
1.3
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
29
298
0.97
0.02
1.1
1.3
mmol/l
7.5
7.5
0.05
21
220
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
13
123
1.06
0.01
1.1
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
54
532
1.02
0.01
1.8
2.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
250
2507
1.00
0.00
1.6
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
67
676
0.99
0.00
1.7
2.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
95
1.05
0.00
1.3
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
145
0.97
0.00
1.1
1.1
—
—
—
0
0
(4024509)
21
215
0.98
0.00
1.7
1.7
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
15
151
0.99
0.00
1.3
1.6
—
68.4
—
0
16
(3028707) Methadone [Presence] in Urine by Screen method
31
309
1.00
0.00
2.1
2.7
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
16
156
1.03
0.00
1.8
2.3
ml
553.9
627.5
0.23
11
111
(3047007) Chlamydophila sp Ab [Presence] in Serum
33
326
1.01
0.00
1.2
1.2
—
—
—
0
0
(44813793)
16
158
1.01
0.00
1.1
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
18
178
1.01
0.00
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
177
1766
1.00
0.00
1.6
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
34
343
0.99
0.00
1.6
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
42
417
1.01
0.00
1.4
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
67
667
1.00
0.00
1.7
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
67
673
1.00
0.00
1.7
2.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
11
113
0.97
0.00
1.7
1.4
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
9
0.00
0.00
0.0
4.2
—
325.8
—
0
9
(3009677) Dengue virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
6
60
1.00
0.00
1.2
1.1
—
3.6
—
0
10
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
68
0.88
0.00
1.8
1.2
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4094501)
61
610
1.00
0.00
1.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
4.5
—
0
5
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
303.2
—
0
5
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(3017400) Magnesium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
2.1
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
69
0.87
0.00
1.3
2.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
58
0.86
0.00
1.6
2.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
10
100
1.00
0.00
2.2
3.4
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_THYROID_PAPILLARY_ADENO_EXALLC – Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
GWS hits: 16
This endpoint is excluded (different definition than used in FinnGen).